noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Company News

Financial Services

Deutsche Investment Trust

02/02/2026 | Press release | Distributed by Public on 02/02/2026 08:29

Annual Report by Investment Company (Form N-CSR)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF

REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number: 811-00043

Deutsche DWS Investment Trust

(Exact Name of Registrant as Specified in Charter)

875 Third Avenue

New York, NY 10022-6225

(Address of Principal Executive Offices) (Zip Code)

Registrant's Telephone Number, including Area Code: (212) 454-4500

Diane Kenneally

100 Summer Street

Boston, MA 02110

(Name and Address of Agent for Service)

Date of fiscal year end:	11/30

Date of reporting period:	11/30/2025

Item 1.	Reports to Stockholders.

	(a)

DWS CROCI^® Equity Dividend Fund

Class A: KDHAX

Annual Shareholder Report - November 30, 2025

This annual shareholder report contains important information about DWS CROCI^® Equity Dividend Fund (the "Fund") for the period December 1, 2024 to November 30, 2025. You can find additional information about the Fund on the Fund's website at dws.com/mutualreports. You can also request this information by contacting us at (800) 728-3337.

This report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(Based on a hypothetical $10,000 investment)

Fund	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Class A	$104	1.06%

Gross expense ratio as of the latest prospectus: 1.02%. See prospectus for any contractual or voluntary waivers; without a waiver, costs would have been higher.

How did the Fund perform last year and what affected its performance?

Class A shares of the Fund returned -3.84% (unadjusted for sales charges) for the period ended November 30, 2025. The Fund's broad-based index, the Russell 1000^® Index, returned 14.09% for the same period, while the Fund's additional, more narrowly based index, the Russell 1000^® Value Index, returned 7.25%.

Individual stock selection and sector allocations each played a role in the Fund's underperformance relative to the Russell 1000^® Value Index. A large portion of the shortfall from selection occurred in the consumer staples sector. The broader sector came under persistent pressure due to rising input costs, a trend toward greater health consciousness, and concerns about the ongoing financial challenges facing many lower-end consumers. These trends contributed to weak relative performance for holdings in The Campbells Co. (2.4%), Conagra Brands, Inc.,* and General Mills, Inc. (1.9%), among others. Spirits producers also lagged amid an accelerating decline in alcohol consumption, weighing on the Fund's positions in Molson Coors Beverage Co. (2.5%) and Constellation Brands, Inc. (2.4%).

Selection in the information technology, materials, energy, and industrials sectors also weighed on Fund performance. In terms of individual stocks, ManpowerGroup, Inc. (2.2%), ONEOK, Inc. (2.6%), and HP, Inc. (2.2%) were the largest detractors outside of consumer staples. A zero weighting in Google parent Alphabet, Inc., which rose on mounting optimism about its ability to capitalize on the growth of artificial intelligence, further hurt relative performance.

With respect to sector allocations, the Fund was hurt by overweights in consumer staples and energy and an underweight in communication services. A zero weighting in the underperforming real estate sector contributed, as did an underweight in consumer discretionary.

Stock selection in health care helped results, as well. The Fund benefited from its zero weighting in UnitedHealth Group, Inc., as well as its overweights in Gilead Sciences, Inc. (2.6%), Medtronic PLC (2.7%), and Johnson & Johnson (2.7%). Outside of health care, Phillip Morris International, Inc.,* the trucking company CH Robinson Worldwide, Inc.,* and State Street Corp. (2.5%) were leading contributors.

Percentages in parentheses are based on the Fund's net assets as of November 30, 2025.

* Not held at November 30, 2025.

Fund Performance

Russell 1000^® Index measures the performance of the large-cap segment of the US equity universe. It is a subset of the Russell 3000^® Index and includes approximately 1,000 of the largest securities based on a combination of their market cap and current index membership. The Russell 1000 represents approximately 93% of the US market. The Russell 1000^® Index is constructed to provide a comprehensive and unbiased barometer for the large-cap segment and is completely reconstituted annually to ensure new and growing equities are included.

The Russell 1000^® Index is a required broad-based index that represents the fund's overall equity market.

Russell 1000^® Value Index measures the performance of the large-cap value segment of the US equity universe. It includes those Russell 1000 companies with relatively lower price-to-book ratios, lower I/B/E/S forecast medium term (2 year) growth and lower sales per share historical growth (5 years). The Russell 1000^® Value Index is constructed to provide a comprehensive and unbiased barometer for the large-cap value segment. The index is completely reconstituted annually to ensure new and growing equities are included and that the represented companies continue to reflect value characteristics.

The Russell 1000^® Value Index is a more narrowly based index that reflects the market sector in which the fund invests.

Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.

Cumulative Growth of an Assumed $10,000 Investment

(Adjusted for Maximum Sales Charge)

	Class A	Russell 1000^®Index	Russell 1000^®Value Index
'15	$9,425	$10,000	$10,000
'15	$9,116	$9,820	$9,785
'16	$8,940	$9,292	$9,279
'16	$9,236	$9,288	$9,277
'16	$9,884	$9,935	$9,945
'16	$9,751	$9,989	$10,154
'16	$9,991	$10,164	$10,312
'16	$10,181	$10,187	$10,401
'16	$10,538	$10,575	$10,703
'16	$10,552	$10,589	$10,786
'16	$10,609	$10,598	$10,763
'16	$10,366	$10,391	$10,597
'16	$10,666	$10,801	$11,202
'16	$10,864	$11,004	$11,482
'17	$10,991	$11,225	$11,564
'17	$11,524	$11,660	$11,979
'17	$11,607	$11,667	$11,857
'17	$11,613	$11,790	$11,835
'17	$11,740	$11,941	$11,823
'17	$11,842	$12,024	$12,016
'17	$11,885	$12,262	$12,176
'17	$12,014	$12,301	$12,034
'17	$12,325	$12,563	$12,391
'17	$12,493	$12,851	$12,481
'17	$12,911	$13,243	$12,863
'17	$12,956	$13,390	$13,051
'18	$13,575	$14,125	$13,555
'18	$12,960	$13,607	$12,908
'18	$12,859	$13,298	$12,681
'18	$12,629	$13,343	$12,723
'18	$12,665	$13,684	$12,798
'18	$12,796	$13,772	$12,830
'18	$13,451	$14,247	$13,338
'18	$13,724	$14,738	$13,535
'18	$13,762	$14,794	$13,562
'18	$13,191	$13,747	$12,859
'18	$13,807	$14,027	$13,243
'18	$12,538	$12,750	$11,972
'19	$13,512	$13,818	$12,904
'19	$14,045	$14,286	$13,316
'19	$14,106	$14,535	$13,400
'19	$14,424	$15,122	$13,876
'19	$13,595	$14,158	$12,984
'19	$14,461	$15,152	$13,916
'19	$14,508	$15,387	$14,031
'19	$14,071	$15,105	$13,618
'19	$14,745	$15,367	$14,104
'19	$15,256	$15,693	$14,301
'19	$15,814	$16,286	$14,744
'19	$16,228	$16,756	$15,149
'20	$15,458	$16,774	$14,823
'20	$13,831	$15,404	$13,388
'20	$11,600	$13,368	$11,100
'20	$12,929	$15,135	$12,348
'20	$13,091	$15,933	$12,771
'20	$13,010	$16,285	$12,686
'20	$13,275	$17,239	$13,188
'20	$13,732	$18,504	$13,733
'20	$13,303	$17,828	$13,396
'20	$12,841	$17,398	$13,219
'20	$14,299	$19,447	$14,998
'20	$14,690	$20,269	$15,573
'21	$14,696	$20,102	$15,430
'21	$14,982	$20,685	$16,363
'21	$16,087	$21,467	$17,325
'21	$16,273	$22,623	$18,018
'21	$16,701	$22,730	$18,439
'21	$16,632	$23,300	$18,228
'21	$16,738	$23,784	$18,373
'21	$17,013	$24,472	$18,738
'21	$16,262	$23,348	$18,086
'21	$16,518	$24,968	$19,004
'21	$16,086	$24,633	$18,334
'21	$17,532	$25,631	$19,491
'22	$17,555	$24,186	$19,037
'22	$17,250	$23,522	$18,816
'22	$17,510	$24,316	$19,347
'22	$17,322	$22,149	$18,256
'22	$17,756	$22,115	$18,611
'22	$16,666	$20,263	$16,985
'22	$17,158	$22,150	$18,111
'22	$16,743	$21,300	$17,571
'22	$15,476	$19,329	$16,030
'22	$17,172	$20,879	$17,674
'22	$18,283	$22,008	$18,779
'22	$17,737	$20,729	$18,022
'23	$18,166	$22,118	$18,955
'23	$17,733	$21,592	$18,287
'23	$17,698	$22,275	$18,203
'23	$17,796	$22,551	$18,477
'23	$16,984	$22,656	$17,765
'23	$17,809	$24,186	$18,945
'23	$18,395	$25,018	$19,611
'23	$18,086	$24,580	$19,081
'23	$17,658	$23,425	$18,345
'23	$16,996	$22,859	$17,698
'23	$17,810	$24,994	$19,033
'23	$18,683	$26,228	$20,087
'24	$18,837	$26,594	$20,108
'24	$19,095	$28,030	$20,850
'24	$20,416	$28,928	$21,892
'24	$19,554	$27,697	$20,957
'24	$19,694	$29,002	$21,621
'24	$19,654	$29,961	$21,418
'24	$20,718	$30,397	$22,513
'24	$21,473	$31,118	$23,117
'24	$21,570	$31,783	$23,438
'24	$21,474	$31,561	$23,180
'24	$22,590	$33,593	$24,660
'24	$21,195	$32,657	$22,974
'25	$21,554	$33,696	$24,037
'25	$22,059	$33,107	$24,134
'25	$21,646	$31,191	$23,464
'25	$20,274	$31,005	$22,749
'25	$20,337	$32,984	$23,548
'25	$20,544	$34,655	$24,353
'25	$20,774	$35,425	$24,493
'25	$21,715	$36,170	$25,273
'25	$21,360	$37,424	$25,651
'25	$20,882	$38,232	$25,764
'25	$21,723	$38,325	$26,448

Yearly periods ended November 30

The Fund's growth of an assumed $10,000 investment is adjusted for the maximum sales charge of 5.75%. This results in a net initial investment of $9,425.

Average Annual Total Returns

Class/Index	1-Year	5-Year	10-Year
Class A Unadjusted for Sales Charge	-3.84%	8.72%	8.71%
Class A Adjusted for the Maximum Sales Charge (max 5.75% load)	-9.37%	7.44%	8.07%
Russell 1000^®Index	14.09%	14.53%	14.38%
Russell 1000^®Value Index	7.25%	12.01%	10.21%

Performance shown is historical. The Fund's past performance is not a good predictor or guarantee of the Fund's future performance. Investment return and principal fluctuate, so your shares may be worth more or less when redeemed. Current performance may be lower or higher than the performance data quoted. The performance graph and returns table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares.Please visit dws.com/en-us/products/mutual-funds for the Fund's most recent month-end performance. Fund performance includes reinvestment of all distributions. Unadjusted returns do not reflect sales charges and would have been lower if they had reflected sales charges.

Key Fund Statistics

Net Assets ($)	777,531,208
Number of Portfolio Holdings	43
Portfolio Turnover Rate (%)	100
Total Net Advisory Fees Paid ($)	5,010,350

What did the Fund invest in?

Holdings-based data is subject to change.

Asset Allocation

Asset Type	% of Net Assets
Common Stocks	100%
Cash Equivalents	0%
Other Assets and Liabilities, Net	0%
Total	100%

Sector Allocation

Sector	% of Net Assets
Consumer Staples	25%
Health Care	19%
Financials	15%
Energy	13%
Information Technology	9%
Industrials	7%
Materials	6%
Consumer Discretionary	5%

Ten Largest Equity Holdings

Holdings	27.5% of Net Assets
Merck & Co., Inc.	2.9%
Amgen, Inc.	2.9%
Coterra Energy, Inc.	2.8%
Bristol-Myers Squibb Co.	2.8%
Devon Energy Corp.	2.8%
Tyson Foods, Inc.	2.7%
Medtronic PLC	2.7%
Johnson & Johnson	2.7%
ONEOK, Inc.	2.6%
Gilead Sciences, Inc.	2.6%

Material Fund Changes

This is a summary of certain changes of the Fund since December 1, 2024. For more information, review the Fund's current prospectus at dws.com/mutualreports, or call (800) 728-3337.

Effective October 1, 2025, the Fund's contractual cap on total annual operating expense for Class A shares changed from 1.03% to 1.06%. The cap excludes certain expenses such as extraordinary expenses, taxes, brokerage, interest expense and acquired fund fees and expenses.

Additional Information

If you wish to view additional information about the Fund, including, but not limited to, its prospectus, quarterly holdings, Board fee evaluation reports, and financial statements and other information, please visit dws.com/mutualreports. For information about the Fund's proxy voting policies and procedures and how the Fund voted proxies related to its portfolio securities, please visit dws.com/en-us/resources/proxy-voting. This additional information is also available free of charge by contacting us at (800) 728-3337.

Householding

In order to reduce the amount of mail you receive and to help reduce expenses, we generally send a single copy of any shareholder report and prospectus to each household. If you do not want the mailing of these documents to be combined with those for other members of your household, please contact your financial representative or call DWS toll free at (800) 728-3337.

Stocks may decline in value. The Fund will be managed using the CROCI^® Investment Process, which is based on portfolio management's belief that, over time, stocks which display more favorable financial metrics (for example, the CROCI^® Economic P/E Ratio) as generated by this process may outperform stocks which display less favorable metrics. This premise may not prove to be correct and prospective investors should evaluate this assumption prior to investing in the Fund. Dividends are not guaranteed. If the dividend-paying stocks held by the Fund reduce or stop paying dividends, the Fund's ability to generate income may be adversely affected. Preferred stocks, a type of dividend-paying stock, present certain additional risks. The Fund may lend securities to approved institutions. Please read the prospectus for details.

This report must be preceded or accompanied by a prospectus. We advise you to consider the Fund's objectives, risks, charges, and expenses carefully before investing. The prospectus contains this and other important information about the Fund, which can be requested by calling (800) 728-3337, contacting your financial representative, or visit dws.com/mutualreportsto view or download a prospectus. Please read the prospectus carefully before you invest.

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

©2026 DWS Group GmbH&Co. KGaA. All rights reserved

DCEDF-TSRA-A

R-103926-2 (01/26)

DWS CROCI^® Equity Dividend Fund

Class C: KDHCX

Annual Shareholder Report - November 30, 2025

What were the Fund costs for the last year?

(Based on a hypothetical $10,000 investment)

Fund	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Class C	$178	1.82%

Gross expense ratio as of the latest prospectus: 1.85%. See prospectus for any contractual or voluntary waivers; without a waiver, costs would have been higher.

How did the Fund perform last year and what affected its performance?

Class C shares of the Fund returned -4.56% (unadjusted for sales charges) for the period ended November 30, 2025. The Fund's broad-based index, the Russell 1000^® Index, returned 14.09% for the same period, while the Fund's additional, more narrowly based index, the Russell 1000^® Value Index, returned 7.25%.

Percentages in parentheses are based on the Fund's net assets as of November 30, 2025.

* Not held at November 30, 2025.

Fund Performance

The Russell 1000^® Index is a required broad-based index that represents the fund's overall equity market.

The Russell 1000^® Value Index is a more narrowly based index that reflects the market sector in which the fund invests.

Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.

Cumulative Growth of an Assumed $10,000 Investment

	Class C	Russell 1000^®Index	Russell 1000^®Value Index
'15	$10,000	$10,000	$10,000
'15	$9,666	$9,820	$9,785
'16	$9,475	$9,292	$9,279
'16	$9,784	$9,288	$9,277
'16	$10,463	$9,935	$9,945
'16	$10,317	$9,989	$10,154
'16	$10,562	$10,164	$10,312
'16	$10,758	$10,187	$10,401
'16	$11,130	$10,575	$10,703
'16	$11,137	$10,589	$10,786
'16	$11,187	$10,598	$10,763
'16	$10,926	$10,391	$10,597
'16	$11,234	$10,801	$11,202
'16	$11,436	$11,004	$11,482
'17	$11,562	$11,225	$11,564
'17	$12,116	$11,660	$11,979
'17	$12,194	$11,667	$11,857
'17	$12,192	$11,790	$11,835
'17	$12,320	$11,941	$11,823
'17	$12,416	$12,024	$12,016
'17	$12,456	$12,262	$12,176
'17	$12,583	$12,301	$12,034
'17	$12,899	$12,563	$12,391
'17	$13,069	$12,851	$12,481
'17	$13,495	$13,243	$12,863
'17	$13,535	$13,390	$13,051
'18	$14,172	$14,125	$13,555
'18	$13,521	$13,607	$12,908
'18	$13,409	$13,298	$12,681
'18	$13,158	$13,343	$12,723
'18	$13,189	$13,684	$12,798
'18	$13,315	$13,772	$12,830
'18	$13,989	$14,247	$13,338
'18	$14,264	$14,738	$13,535
'18	$14,299	$14,794	$13,562
'18	$13,695	$13,747	$12,859
'18	$14,332	$14,027	$13,243
'18	$13,005	$12,750	$11,972
'19	$14,005	$13,818	$12,904
'19	$14,548	$14,286	$13,316
'19	$14,600	$14,535	$13,400
'19	$14,922	$15,122	$13,876
'19	$14,061	$14,158	$12,984
'19	$14,954	$15,152	$13,916
'19	$15,000	$15,387	$14,031
'19	$14,539	$15,105	$13,618
'19	$15,222	$15,367	$14,104
'19	$15,737	$15,693	$14,301
'19	$16,303	$16,286	$14,744
'19	$16,716	$16,756	$15,149
'20	$15,913	$16,774	$14,823
'20	$14,229	$15,404	$13,388
'20	$11,925	$13,368	$11,100
'20	$13,285	$15,135	$12,348
'20	$13,440	$15,933	$12,771
'20	$13,348	$16,285	$12,686
'20	$13,612	$17,239	$13,188
'20	$14,070	$18,504	$13,733
'20	$13,622	$17,828	$13,396
'20	$13,142	$17,398	$13,219
'20	$14,626	$19,447	$14,998
'20	$15,015	$20,269	$15,573
'21	$15,010	$20,102	$15,430
'21	$15,294	$20,685	$16,363
'21	$16,408	$21,467	$17,325
'21	$16,586	$22,623	$18,018
'21	$17,012	$22,730	$18,439
'21	$16,929	$23,300	$18,228
'21	$17,025	$23,784	$18,373
'21	$17,294	$24,472	$18,738
'21	$16,520	$23,348	$18,086
'21	$16,769	$24,968	$19,004
'21	$16,319	$24,633	$18,334
'21	$17,776	$25,631	$19,491
'22	$17,783	$24,186	$19,037
'22	$17,467	$23,522	$18,816
'22	$17,714	$24,316	$19,347
'22	$17,514	$22,149	$18,256
'22	$17,938	$22,115	$18,611
'22	$16,827	$20,263	$16,985
'22	$17,312	$22,150	$18,111
'22	$16,882	$21,300	$17,571
'22	$15,592	$19,329	$16,030
'22	$17,292	$20,879	$17,674
'22	$18,398	$22,008	$18,779
'22	$17,837	$20,729	$18,022
'23	$18,259	$22,118	$18,955
'23	$17,813	$21,592	$18,287
'23	$17,765	$22,275	$18,203
'23	$17,854	$22,551	$18,477
'23	$17,027	$22,656	$17,765
'23	$17,844	$24,186	$18,945
'23	$18,418	$25,018	$19,611
'23	$18,099	$24,580	$19,081
'23	$17,659	$23,425	$18,345
'23	$16,984	$22,859	$17,698
'23	$17,790	$24,994	$19,033
'23	$18,649	$26,228	$20,087
'24	$18,789	$26,594	$20,108
'24	$19,036	$28,030	$20,850
'24	$20,340	$28,928	$21,892
'24	$19,469	$27,697	$20,957
'24	$19,595	$29,002	$21,621
'24	$19,539	$29,961	$21,418
'24	$20,581	$30,397	$22,513
'24	$21,320	$31,118	$23,117
'24	$21,401	$31,783	$23,438
'24	$21,292	$31,561	$23,180
'24	$22,383	$33,593	$24,660
'24	$20,986	$32,657	$22,974
'25	$21,331	$33,696	$24,037
'25	$21,816	$33,107	$24,134
'25	$21,393	$31,191	$23,464
'25	$20,027	$31,005	$22,749
'25	$20,074	$32,984	$23,548
'25	$20,267	$34,655	$24,353
'25	$20,482	$35,425	$24,493
'25	$21,394	$36,170	$25,273
'25	$21,032	$37,424	$25,651
'25	$20,544	$38,232	$25,764
'25	$21,362	$38,325	$26,448

Yearly periods ended November 30

Average Annual Total Returns

Class/Index	1-Year	5-Year	10-Year
Class C Unadjusted for Sales Charge	-4.56%	7.87%	7.89%
Class C Adjusted for the Maximum Sales Charge (max 1.00% CDSC)	-5.44%	7.87%	7.89%
Russell 1000^®Index	14.09%	14.53%	14.38%
Russell 1000^®Value Index	7.25%	12.01%	10.21%

Key Fund Statistics

Net Assets ($)	777,531,208
Number of Portfolio Holdings	43
Portfolio Turnover Rate (%)	100
Total Net Advisory Fees Paid ($)	5,010,350

What did the Fund invest in?

Holdings-based data is subject to change.

Asset Allocation

Asset Type	% of Net Assets
Common Stocks	100%
Cash Equivalents	0%
Other Assets and Liabilities, Net	0%
Total	100%

Sector Allocation

Sector	% of Net Assets
Consumer Staples	25%
Health Care	19%
Financials	15%
Energy	13%
Information Technology	9%
Industrials	7%
Materials	6%
Consumer Discretionary	5%

Ten Largest Equity Holdings

Holdings	27.5% of Net Assets
Merck & Co., Inc.	2.9%
Amgen, Inc.	2.9%
Coterra Energy, Inc.	2.8%
Bristol-Myers Squibb Co.	2.8%
Devon Energy Corp.	2.8%
Tyson Foods, Inc.	2.7%
Medtronic PLC	2.7%
Johnson & Johnson	2.7%
ONEOK, Inc.	2.6%
Gilead Sciences, Inc.	2.6%

Additional Information

Householding

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

©2026 DWS Group GmbH&Co. KGaA. All rights reserved

DCEDF-TSRA-C

R-103926-2 (01/26)

DWS CROCI^® Equity Dividend Fund

Class S: KDHSX

Annual Shareholder Report - November 30, 2025

This report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(Based on a hypothetical $10,000 investment)

Fund	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Class S	$81	0.82%

Gross expense ratio as of the latest prospectus: 0.78%. See prospectus for any contractual or voluntary waivers; without a waiver, costs would have been higher.

How did the Fund perform last year and what affected its performance?

Class S shares of the Fund returned -3.61% for the period ended November 30, 2025. The Fund's broad-based index, the Russell 1000^® Index, returned 14.09% for the same period, while the Fund's additional, more narrowly based index, the Russell 1000^® Value Index, returned 7.25%.

Percentages in parentheses are based on the Fund's net assets as of November 30, 2025.

* Not held at November 30, 2025.

Fund Performance

The Russell 1000^® Index is a required broad-based index that represents the fund's overall equity market.

The Russell 1000^® Value Index is a more narrowly based index that reflects the market sector in which the fund invests.

Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.

Cumulative Growth of an Assumed $10,000 Investment

	Class S	Russell 1000^®Index	Russell 1000^®Value Index
'15	$10,000	$10,000	$10,000
'15	$9,674	$9,820	$9,785
'16	$9,491	$9,292	$9,279
'16	$9,808	$9,288	$9,277
'16	$10,498	$9,935	$9,945
'16	$10,358	$9,989	$10,154
'16	$10,614	$10,164	$10,312
'16	$10,820	$10,187	$10,401
'16	$11,202	$10,575	$10,703
'16	$11,218	$10,589	$10,786
'16	$11,279	$10,598	$10,763
'16	$11,026	$10,391	$10,597
'16	$11,345	$10,801	$11,202
'16	$11,561	$11,004	$11,482
'17	$11,697	$11,225	$11,564
'17	$12,268	$11,660	$11,979
'17	$12,358	$11,667	$11,857
'17	$12,365	$11,790	$11,835
'17	$12,508	$11,941	$11,823
'17	$12,615	$12,024	$12,016
'17	$12,665	$12,262	$12,176
'17	$12,805	$12,301	$12,034
'17	$13,137	$12,563	$12,391
'17	$13,322	$12,851	$12,481
'17	$13,769	$13,243	$12,863
'17	$13,821	$13,390	$13,051
'18	$14,484	$14,125	$13,555
'18	$13,830	$13,607	$12,908
'18	$13,726	$13,298	$12,681
'18	$13,480	$13,343	$12,723
'18	$13,523	$13,684	$12,798
'18	$13,664	$13,772	$12,830
'18	$14,369	$14,247	$13,338
'18	$14,663	$14,738	$13,535
'18	$14,705	$14,794	$13,562
'18	$14,097	$13,747	$12,859
'18	$14,756	$14,027	$13,243
'18	$13,403	$12,750	$11,972
'19	$14,448	$13,818	$12,904
'19	$15,020	$14,286	$13,316
'19	$15,088	$14,535	$13,400
'19	$15,432	$15,122	$13,876
'19	$14,547	$14,158	$12,984
'19	$15,477	$15,152	$13,916
'19	$15,531	$15,387	$14,031
'19	$15,067	$15,105	$13,618
'19	$15,791	$15,367	$14,104
'19	$16,341	$15,693	$14,301
'19	$16,942	$16,286	$14,744
'19	$17,384	$16,756	$15,149
'20	$16,562	$16,774	$14,823
'20	$14,824	$15,404	$13,388
'20	$12,435	$13,368	$11,100
'20	$13,860	$15,135	$12,348
'20	$14,036	$15,933	$12,771
'20	$13,951	$16,285	$12,686
'20	$14,239	$17,239	$13,188
'20	$14,732	$18,504	$13,733
'20	$14,273	$17,828	$13,396
'20	$13,780	$17,398	$13,219
'20	$15,345	$19,447	$14,998
'20	$15,766	$20,269	$15,573
'21	$15,776	$20,102	$15,430
'21	$16,083	$20,685	$16,363
'21	$17,274	$21,467	$17,325
'21	$17,474	$22,623	$18,018
'21	$17,937	$22,730	$18,439
'21	$17,865	$23,300	$18,228
'21	$17,982	$23,784	$18,373
'21	$18,281	$24,472	$18,738
'21	$17,478	$23,348	$18,086
'21	$17,757	$24,968	$19,004
'21	$17,294	$24,633	$18,334
'21	$18,856	$25,631	$19,491
'22	$18,880	$24,186	$19,037
'22	$18,556	$23,522	$18,816
'22	$18,837	$24,316	$19,347
'22	$18,638	$22,149	$18,256
'22	$19,109	$22,115	$18,611
'22	$17,941	$20,263	$16,985
'22	$18,470	$22,150	$18,111
'22	$18,031	$21,300	$17,571
'22	$16,667	$19,329	$16,030
'22	$18,499	$20,879	$17,674
'22	$19,699	$22,008	$18,779
'22	$19,113	$20,729	$18,022
'23	$19,583	$22,118	$18,955
'23	$19,117	$21,592	$18,287
'23	$19,082	$22,275	$18,203
'23	$19,195	$22,551	$18,477
'23	$18,322	$22,656	$17,765
'23	$19,216	$24,186	$18,945
'23	$19,848	$25,018	$19,611
'23	$19,523	$24,580	$19,081
'23	$19,061	$23,425	$18,345
'23	$18,352	$22,859	$17,698
'23	$19,236	$24,994	$19,033
'23	$20,183	$26,228	$20,087
'24	$20,349	$26,594	$20,108
'24	$20,632	$28,030	$20,850
'24	$22,068	$28,928	$21,892
'24	$21,140	$27,697	$20,957
'24	$21,292	$29,002	$21,621
'24	$21,253	$29,961	$21,418
'24	$22,408	$30,397	$22,513
'24	$23,229	$31,118	$23,117
'24	$23,342	$31,783	$23,438
'24	$23,243	$31,561	$23,180
'24	$24,455	$33,593	$24,660
'24	$22,950	$32,657	$22,974
'25	$23,343	$33,696	$24,037
'25	$23,894	$33,107	$24,134
'25	$23,451	$31,191	$23,464
'25	$21,969	$31,005	$22,749
'25	$22,041	$32,984	$23,548
'25	$22,269	$34,655	$24,353
'25	$22,526	$35,425	$24,493
'25	$23,547	$36,170	$25,273
'25	$23,169	$37,424	$25,651
'25	$22,655	$38,232	$25,764
'25	$23,571	$38,325	$26,448

Yearly periods ended November 30

Average Annual Total Returns

Class/Index	1-Year	5-Year	10-Year
Class S No Sales Charge	-3.61%	8.96%	8.95%
Russell 1000^®Index	14.09%	14.53%	14.38%
Russell 1000^®Value Index	7.25%	12.01%	10.21%

Key Fund Statistics

Net Assets ($)	777,531,208
Number of Portfolio Holdings	43
Portfolio Turnover Rate (%)	100
Total Net Advisory Fees Paid ($)	5,010,350

What did the Fund invest in?

Holdings-based data is subject to change.

Asset Allocation

Asset Type	% of Net Assets
Common Stocks	100%
Cash Equivalents	0%
Other Assets and Liabilities, Net	0%
Total	100%

Sector Allocation

Sector	% of Net Assets
Consumer Staples	25%
Health Care	19%
Financials	15%
Energy	13%
Information Technology	9%
Industrials	7%
Materials	6%
Consumer Discretionary	5%

Ten Largest Equity Holdings

Holdings	27.5% of Net Assets
Merck & Co., Inc.	2.9%
Amgen, Inc.	2.9%
Coterra Energy, Inc.	2.8%
Bristol-Myers Squibb Co.	2.8%
Devon Energy Corp.	2.8%
Tyson Foods, Inc.	2.7%
Medtronic PLC	2.7%
Johnson & Johnson	2.7%
ONEOK, Inc.	2.6%
Gilead Sciences, Inc.	2.6%

Material Fund Changes

This is a summary of certain changes of the Fund since December 1, 2024. For more information, review the Fund's current prospectus at dws.com/mutualreports, or call (800) 728-3337.

Effective October 1, 2025, the Fund's contractual cap on total annual operating expense for Class S shares changed from 0.88% to 0.91%. The cap excludes certain expenses such as extraordinary expenses, taxes, brokerage, interest expense and acquired fund fees and expenses.

Additional Information

Householding

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

©2026 DWS Group GmbH&Co. KGaA. All rights reserved

DCEDF-TSRA-S

R-103926-2 (01/26)

DWS CROCI^® Equity Dividend Fund

Institutional Class: KDHIX

Annual Shareholder Report - November 30, 2025

This report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(Based on a hypothetical $10,000 investment)

Fund	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Institutional Class	$79	0.80%

Gross expense ratio as of the latest prospectus: 0.76%. See prospectus for any contractual or voluntary waivers; without a waiver, costs would have been higher.

How did the Fund perform last year and what affected its performance?

Institutional Class shares of the Fund returned -3.60% for the period ended November 30, 2025. The Fund's broad-based index, the Russell 1000^® Index, returned 14.09% for the same period, while the Fund's additional, more narrowly based index, the Russell 1000^® Value Index, returned 7.25%.

Percentages in parentheses are based on the Fund's net assets as of November 30, 2025.

* Not held at November 30, 2025.

Fund Performance

The Russell 1000^® Index is a required broad-based index that represents the fund's overall equity market.

The Russell 1000^® Value Index is a more narrowly based index that reflects the market sector in which the fund invests.

Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.

Cumulative Growth of an Assumed $1,000,000 Investment

	Institutional Class	Russell 1000^®Index	Russell 1000^®Value Index
'15	$1,000,000	$1,000,000	$1,000,000
'15	$967,382	$982,010	$978,494
'16	$948,929	$929,154	$927,933
'16	$980,760	$928,835	$927,699
'16	$1,049,744	$993,538	$994,526
'16	$1,035,828	$998,941	$1,015,417
'16	$1,061,340	$1,016,434	$1,031,189
'16	$1,081,941	$1,018,736	$1,040,106
'16	$1,120,182	$1,057,544	$1,070,306
'16	$1,121,814	$1,058,949	$1,078,558
'16	$1,127,924	$1,059,787	$1,076,310
'16	$1,102,609	$1,039,121	$1,059,652
'16	$1,134,487	$1,080,087	$1,120,174
'16	$1,156,046	$1,100,378	$1,148,170
'17	$1,169,713	$1,122,505	$1,156,350
'17	$1,226,738	$1,165,955	$1,197,902
'17	$1,235,788	$1,166,692	$1,185,699
'17	$1,236,735	$1,179,027	$1,183,474
'17	$1,250,706	$1,194,074	$1,182,314
'17	$1,261,639	$1,202,411	$1,201,642
'17	$1,266,639	$1,226,223	$1,217,612
'17	$1,280,686	$1,230,059	$1,203,429
'17	$1,313,916	$1,256,253	$1,239,072
'17	$1,332,334	$1,285,066	$1,248,068
'17	$1,377,064	$1,324,255	$1,286,286
'17	$1,382,225	$1,339,018	$1,305,062
'18	$1,448,538	$1,412,521	$1,355,518
'18	$1,383,186	$1,360,663	$1,290,791
'18	$1,372,837	$1,329,779	$1,268,085
'18	$1,348,197	$1,334,299	$1,272,271
'18	$1,352,545	$1,368,358	$1,279,823
'18	$1,366,683	$1,377,207	$1,282,993
'18	$1,437,118	$1,424,736	$1,333,773
'18	$1,466,506	$1,473,829	$1,353,487
'18	$1,470,803	$1,479,425	$1,356,171
'18	$1,410,069	$1,374,736	$1,285,947
'18	$1,476,414	$1,402,713	$1,324,339
'18	$1,341,223	$1,274,958	$1,197,169
'19	$1,445,723	$1,381,804	$1,290,350
'19	$1,502,969	$1,428,590	$1,331,579
'19	$1,509,959	$1,453,461	$1,340,045
'19	$1,544,302	$1,512,158	$1,387,578
'19	$1,455,793	$1,415,797	$1,298,361
'19	$1,549,017	$1,515,192	$1,391,563
'19	$1,554,631	$1,538,723	$1,403,098
'19	$1,508,312	$1,510,540	$1,361,840
'19	$1,580,652	$1,536,723	$1,410,427
'19	$1,635,955	$1,569,292	$1,430,142
'19	$1,696,055	$1,628,598	$1,474,357
'19	$1,740,665	$1,675,630	$1,514,915
'20	$1,658,388	$1,677,439	$1,482,324
'20	$1,484,204	$1,540,363	$1,338,766
'20	$1,245,156	$1,336,805	$1,109,978
'20	$1,388,308	$1,513,454	$1,234,764
'20	$1,405,651	$1,593,306	$1,277,077
'20	$1,397,411	$1,628,540	$1,268,600
'20	$1,426,205	$1,723,901	$1,318,752
'20	$1,475,522	$1,850,430	$1,373,282
'20	$1,429,901	$1,782,801	$1,339,550
'20	$1,380,552	$1,739,809	$1,321,945
'20	$1,537,545	$1,944,684	$1,499,765
'20	$1,579,706	$2,026,897	$1,557,265
'21	$1,580,949	$2,010,204	$1,543,003
'21	$1,612,021	$2,068,461	$1,636,251
'21	$1,731,306	$2,146,738	$1,732,535
'21	$1,751,342	$2,262,298	$1,801,821
'21	$1,797,991	$2,273,037	$1,843,883
'21	$1,790,885	$2,329,993	$1,822,768
'21	$1,802,557	$2,378,396	$1,837,336
'21	$1,832,842	$2,447,232	$1,873,773
'21	$1,752,163	$2,334,821	$1,808,551
'21	$1,780,408	$2,496,828	$1,900,385
'21	$1,733,756	$2,463,334	$1,833,415
'21	$1,890,276	$2,563,112	$1,949,078
'22	$1,893,015	$2,418,603	$1,903,676
'22	$1,860,489	$2,352,233	$1,881,585
'22	$1,889,014	$2,431,610	$1,934,700
'22	$1,869,028	$2,214,855	$1,825,576
'22	$1,916,236	$2,211,488	$1,861,064
'22	$1,799,078	$2,026,276	$1,698,459
'22	$1,852,491	$2,215,002	$1,811,088
'22	$1,808,442	$2,129,954	$1,757,126
'22	$1,672,003	$1,932,875	$1,603,049
'22	$1,855,955	$2,087,892	$1,767,410
'22	$1,976,608	$2,200,842	$1,877,858
'22	$1,917,854	$2,072,867	$1,802,158
'23	$1,964,951	$2,211,842	$1,895,546
'23	$1,918,584	$2,159,210	$1,828,711
'23	$1,915,046	$2,227,513	$1,820,289
'23	$1,926,080	$2,255,114	$1,847,715
'23	$1,838,547	$2,265,618	$1,776,452
'23	$1,928,192	$2,418,633	$1,894,457
'23	$1,991,970	$2,501,806	$1,961,075
'23	$1,959,339	$2,458,042	$1,908,133
'23	$1,913,128	$2,342,523	$1,834,499
'23	$1,841,731	$2,285,906	$1,769,774
'23	$1,930,697	$2,499,399	$1,903,303
'23	$2,025,462	$2,622,784	$2,008,732
'24	$2,042,561	$2,659,361	$2,010,812
'24	$2,070,930	$2,802,970	$2,084,990
'24	$2,214,762	$2,892,825	$2,189,229
'24	$2,121,665	$2,769,729	$2,095,715
'24	$2,137,311	$2,900,155	$2,162,149
'24	$2,133,521	$2,996,141	$2,141,811
'24	$2,249,400	$3,039,743	$2,251,304
'24	$2,332,171	$3,111,795	$2,311,695
'24	$2,343,367	$3,178,331	$2,343,781
'24	$2,333,440	$3,156,123	$2,317,986
'24	$2,454,956	$3,359,311	$2,466,010
'24	$2,303,815	$3,265,654	$2,297,353
'25	$2,343,748	$3,369,605	$2,403,686
'25	$2,398,550	$3,310,667	$2,413,446
'25	$2,354,344	$3,119,067	$2,346,419
'25	$2,205,622	$3,100,504	$2,274,903
'25	$2,212,887	$3,298,432	$2,354,787
'25	$2,236,175	$3,465,469	$2,435,280
'25	$2,261,561	$3,542,477	$2,449,263
'25	$2,364,399	$3,617,038	$2,527,322
'25	$2,326,331	$3,742,431	$2,565,074
'25	$2,274,268	$3,823,198	$2,576,400
'25	$2,366,679	$3,832,517	$2,644,838

Yearly periods ended November 30

Average Annual Total Returns

Class/Index	1-Year	5-Year	10-Year
Institutional Class No Sales Charge	-3.60%	9.01%	9.00%
Russell 1000^®Index	14.09%	14.53%	14.38%
Russell 1000^®Value Index	7.25%	12.01%	10.21%

Key Fund Statistics

Net Assets ($)	777,531,208
Number of Portfolio Holdings	43
Portfolio Turnover Rate (%)	100
Total Net Advisory Fees Paid ($)	5,010,350

What did the Fund invest in?

Holdings-based data is subject to change.

Asset Allocation

Asset Type	% of Net Assets
Common Stocks	100%
Cash Equivalents	0%
Other Assets and Liabilities, Net	0%
Total	100%

Sector Allocation

Sector	% of Net Assets
Consumer Staples	25%
Health Care	19%
Financials	15%
Energy	13%
Information Technology	9%
Industrials	7%
Materials	6%
Consumer Discretionary	5%

Ten Largest Equity Holdings

Holdings	27.5% of Net Assets
Merck & Co., Inc.	2.9%
Amgen, Inc.	2.9%
Coterra Energy, Inc.	2.8%
Bristol-Myers Squibb Co.	2.8%
Devon Energy Corp.	2.8%
Tyson Foods, Inc.	2.7%
Medtronic PLC	2.7%
Johnson & Johnson	2.7%
ONEOK, Inc.	2.6%
Gilead Sciences, Inc.	2.6%

Material Fund Changes

This is a summary of certain changes of the Fund since December 1, 2024. For more information, review the Fund's current prospectus at dws.com/mutualreports, or call (800) 728-3337.

Effective October 1, 2025, the Fund's contractual cap on total annual operating expense for Institutional Class shares changed from 0.78% to 0.81%. The cap excludes certain expenses such as extraordinary expenses, taxes, brokerage, interest expense and acquired fund fees and expenses.

Additional Information

Householding

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

©2026 DWS Group GmbH&Co. KGaA. All rights reserved

DCEDF-TSRA-I

R-103926-2 (01/26)


	(b) Not applicable

Item 2.	Code of Ethics.

	As of the end of the period covered by this report, the registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR that applies to its Principal Executive Officer and Principal Financial Officer. There have been no amendments to, or waivers from, a provision of the code of ethics during the period covered by this report that would require disclosure under Item 2. A copy of the code of ethics is filed as an exhibit to this Form N-CSR.

Item 3.	Audit Committee Financial Expert.

	The fund's audit committee is comprised solely of trustees who are "independent" (as such term has been defined by the Securities and Exchange Commission ("SEC") in regulations implementing Section 407 of the Sarbanes-Oxley Act (the "Regulations")). The fund's Board of Trustees has determined that there are several "audit committee financial experts" (as such term has been defined by the Regulations) serving on the fund's audit committee including Ms. Catherine Schrand, the chair of the fund's audit committee. An "audit committee financial expert" is not an "expert" for any purpose, including for purposes of Section 11 of the Securities Act of 1933 and the designation or identification of a person as an "audit committee financial expert" does not impose on such person any duties, obligations or liability that are greater than the duties, obligations and liability imposed on such person as a member of the audit committee and board of directors in the absence of such designation or identification.

Item 4.	Principal Accountant Fees and Services.

DWS CROCI Equity dividend Fund

form n-csr disclosure re: AUDIT FEES

The following table shows the amount of fees that Ernst & Young LLP ("EY"), the Fund's Independent Registered Public Accounting Firm, billed to the Fund during the Fund's last two fiscal years. The Audit Committee approved in advance all audit services and non-audit services that EY provided to the Fund.

Services that the Fund's Independent Registered Public Accounting Firm Billed to the Fund

Fiscal Year Ended November 30,	Audit Fees Billed to Fund	Audit-Related Fees Billed to Fund	Tax Fees Billed to Fund	All Other Fees Billed to Fund
2025	$53,074	$0	$5,969	$0
2024	$53,074	$0	$5,969	$0

The above "Tax Fees" were billed for professional services rendered for tax preparation.

Services that the Fund's Independent Registered Public Accounting Firm Billed to the Adviser and Affiliated Fund Service Providers

The following table shows the amount of fees billed by EY to DWS Investment Management Americas, Inc. ("DIMA" or the "Adviser"), and any entity controlling, controlled by or under common control with DIMA ("Control Affiliate") that provides ongoing services to the Fund ("Affiliated Fund Service Provider"), for engagements directly related to the Fund's operations and financial reporting, during the Fund's last two fiscal years.

Fiscal Year Ended November 30,	Audit-Related Fees Billed to Adviser and Affiliated Fund Service Providers	Tax Fees Billed to Adviser and Affiliated Fund Service Providers	All Other Fees Billed to Adviser and Affiliated Fund Service Providers
2025	$0	$745,563	$0
2024	$0	$628,206	$0

The above "Tax Fees" were billed in connection with tax compliance services and agreed upon procedures.

Non-Audit Services

The following table shows the amount of fees that EY billed during the Fund's last two fiscal years for non-audit services. The Audit Committee pre-approved all non-audit services that EY provided to the Adviser and any Affiliated Fund Service Provider that related directly to the Fund's operations and financial reporting. The Audit Committee requested and received information from EY about any non-audit services that EY rendered during the Fund's last fiscal year to the Adviser and any Affiliated Fund Service Provider. The Committee considered this information in evaluating EY's independence.

Fiscal Year Ended November 30,	Total Non-Audit Fees Billed to Fund (A)	Total Non-Audit Fees billed to Adviser and Affiliated Fund Service Providers (engagements related directly to the operations and financial reporting of the Fund) (B)	Total Non-Audit Fees billed to Adviser and Affiliated Fund Service Providers (all other engagements) (C)	Total of (A), (B) and (C)
2025	$5,969	$745,563	$0	$751,532
2024	$5,969	$628,206	$0	$634,175

All other engagement fees were billed for services in connection with agreed upon procedures and tax compliance for DIMA and other related entities.

Audit Committee Pre-Approval Policies and Procedures. Generally, each Fund's Audit Committee must pre approve (i) all services to be performed for a Fund by a Fund's Independent Registered Public Accounting Firm and (ii) all non-audit services to be performed by a Fund's Independent Registered Public Accounting Firm for the DIMA Entities with respect to operations and financial reporting of the Fund, except that the Chairperson or Vice Chairperson of each Fund's Audit Committee may grant the pre-approval for non-audit services described in items (i) and (ii) above for non-prohibited services for engagements of less than $100,000. All such delegated pre approvals shall be presented to each Fund's Audit Committee no later than the next Audit Committee meeting.

There were no amounts that were approved by the Audit Committee pursuant to the de minimis exception under Rule 2-01 of Regulation S-X.

According to the registrant's principal Independent Registered Public Accounting Firm, substantially all of the principal Independent Registered Public Accounting Firm's hours spent on auditing the registrant's financial statements were attributed to work performed by full-time permanent employees of the principal Independent Registered Public Accounting Firm and (i) and (j) are not applicable.

***

In connection with the audit of the 2024 and 2025 financial statements, the Fund entered into an engagement letter with EY. The terms of the engagement letter required by EY, and agreed to by the Audit Committee, include a provision mandating the use of mediation and arbitration to resolve any controversy or claim between the parties arising out of or relating to the engagement letter or services provided thereunder.

***


Item 5.	Audit Committee of Listed Registrants

	Not applicable

Item 6.	Investments.

	Not applicable

Item 7.	Financial Statements and Financial Highlights for Open-End Management Investment Companies.

	(a)

November 30, 2025

Annual Financial Statements and Other Information

DWS CROCI®Equity Dividend Fund

Contents

3	Investment Portfolio
7	Statement of Assets and Liabilities
9	Statement of Operations
10	Statements of Changes in Net Assets
11	Financial Highlights
15	Notes to Financial Statements
27	Report of Independent Registered Public Accounting Firm
29	Tax Information
30	Advisory Agreement Board Considerations and Fee Evaluation

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

DWS CROCI®Equity Dividend Fund

Investment Portfolioas of November 30, 2025

	Shares		Value ($)
Common Stocks 99.5%
Consumer Discretionary 4.7%
Distributors 2.3%
Genuine Parts Co.		136,893	17,850,847
Specialty Retail 2.4%
Best Buy Co., Inc.		231,359	18,342,142
Consumer Staples 25.1%
Beverages 9.1%
Brown-Forman Corp. "B" (a)		538,115	15,594,573
Constellation Brands, Inc. "A"		139,610	19,040,012
Keurig Dr Pepper, Inc.		608,945	16,989,565
Molson Coors Beverage Co. "B" (a)		419,851	19,527,270
			71,151,420
Consumer Staples Distribution & Retail 2.3%
Target Corp.		196,083	17,769,041
Food Products 11.9%
General Mills, Inc.		316,236	14,973,775
Kraft Heinz Co.		744,202	18,984,593
The Campbell's Co.		610,592	18,610,844
The J.M. Smucker Co.		180,159	18,768,965
Tyson Foods, Inc. "A"		365,885	21,239,624
			92,577,801
Tobacco 1.8%
Altria Group, Inc.		237,665	14,024,612
Energy 13.0%
Energy Equipment & Services 4.8%
Halliburton Co.		715,665	18,764,736
SLB Ltd.		508,298	18,420,720
			37,185,456
Oil, Gas & Consumable Fuels 8.2%
Coterra Energy, Inc.		810,597	21,756,423
Devon Energy Corp.		584,681	21,668,278
ONEOK, Inc.		276,777	20,154,901
			63,579,602

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

	Shares		Value ($)
Financials 15.0%
Banks 10.1%
Huntington Bancshares, Inc.		1,222,563	19,927,777
M&T Bank Corp.		104,399	19,858,778
PNC Financial Services Group, Inc.		100,837	19,231,633
Regions Financial Corp.		782,634	19,918,035
			78,936,223
Capital Markets 2.5%
State Street Corp.		160,962	19,157,697
Financial Services 2.4%
Fidelity National Information Services, Inc.		285,339	18,766,746
Health Care 19.2%
Biotechnology 5.5%
Amgen, Inc.		65,349	22,575,465
Gilead Sciences, Inc.		158,857	19,990,565
			42,566,030
Health Care Equipment & Supplies 2.7%
Medtronic PLC		201,615	21,236,108
Pharmaceuticals 11.0%
Bristol-Myers Squibb Co.		440,493	21,672,256
Johnson & Johnson		100,609	20,818,014
Merck & Co., Inc.		217,269	22,776,309
Pfizer, Inc.		771,636	19,861,911
			85,128,490
Industrials 7.0%
Aerospace & Defense 2.3%
Lockheed Martin Corp.		38,968	17,841,888
Machinery 2.5%
PACCAR, Inc.		189,418	19,968,446
Professional Services 2.2%
ManpowerGroup, Inc.		590,974	16,996,412
Information Technology 9.0%
IT Services 4.6%
Accenture PLC "A"		75,260	18,815,000
Amdocs Ltd.		224,744	17,188,421
			36,003,421
Semiconductors & Semiconductor Equipment 2.2%
QUALCOMM, Inc.		103,798	17,447,406

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

	Shares		Value ($)
Technology Hardware, Storage & Peripherals 2.2%
HP, Inc.		688,234	16,806,674
Materials 6.5%
Chemicals 2.3%
PPG Industries, Inc.		179,230	17,930,169
Containers & Packaging 4.2%
Amcor PLC		2,297,585	19,575,424
Smurfit WestRock PLC		355,302	12,680,729
			32,256,153
Total Common Stocks(Cost $774,088,005)			773,522,784
Securities Lending Collateral 2.0%
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares" , 3.88% (b) (c) (Cost $15,736,500)		15,736,500	15,736,500
Cash Equivalents 0.4%
DWS Central Cash Management Government Fund, 4.0% (b) (Cost $3,122,502)		3,122,502	3,122,502

	% of Net Assets	Value ($)
Total Investment Portfolio(Cost $792,947,007)	101.9	792,381,786
Other Assets and Liabilities, Net	(1.9 )	(14,850,578 )
Net Assets	100.0	777,531,208

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

A summary of the Fund's transactions with affiliated investments during the year ended November 30, 2025 are as follows:

Value ($) at 11/30/2024	Pur- chases Cost ($)	Sales Proceeds ($)	Net Real- ized Gain/ (Loss) ($)	Net Change in Unreal- ized Appreci- ation (Depreci- ation) ($)	Income ($)	Capital Gain Distri- butions ($)	Number of Shares at 11/30/2025	Value ($) at 11/30/2025
Securities Lending Collateral 2.0%
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares" , 3.88% (b) (c)
-	15,736,500 (d)	-	-	-	4,493	-	15,736,500	15,736,500
Cash Equivalents 0.4%
DWS Central Cash Management Government Fund, 4.0% (b)
2,089,848	101,170,344	100,137,690	-	-	190,413	-	3,122,502	3,122,502
2,089,848	116,906,844	100,137,690	-	-	194,906	-	18,859,002	18,859,002

(a)	All or a portion of these securities were on loan. In addition, "Other Assets and Liabilities, Net" may include pending sales that are also on loan. The value of securities loaned at November 30, 2025 amounted to $21,065,467, which is 2.7% of net assets.
(b)	Affiliated fund managed by DWS Investment Management Americas, Inc. The rate shown is the annualized seven-day yield at period end.
(c)	Represents cash collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates. In addition, the Fund held non-cash U.S. Treasury securities collateral having a value of $5,595,865.
(d)	Represents the net increase (purchase cost) or decrease (sales proceeds) in the amount invested in cash collateral for the year ended November 30, 2025.

Fair Value Measurements

Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.

The following is a summary of the inputs used as of November 30, 2025 in valuing the Fund's investments. For information on the Fund's policy regarding the valuation of investments, please refer to the Security Valuation section of Note A in the accompanying Notes to Financial Statements.

Assets	Level 1	Level 2	Level 3	Total
Common Stocks (a)	$773,522,784	$-	$-	$773,522,784
Short-Term Investments (a)	18,859,002	-	-	18,859,002
Total	$792,381,786	$-	$-	$792,381,786

(a)	See Investment Portfolio for additional detailed categorizations.

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

Statement of Assets and Liabilities

as of November 30, 2025

Assets
Investments in non-affiliated securities, at value (cost $774,088,005) - including $21,065,467 of securities loaned	$773,522,784
Investment in DWS Government & Agency Securities Portfolio (cost $15,736,500)*	15,736,500
Investment in DWS Central Cash Management Government Fund (cost $3,122,502)	3,122,502
Foreign currency, at value (cost $62)	49
Receivable for Fund shares sold	20,728
Dividends receivable	1,994,801
Affiliated securities lending income receivable	1,141
Other assets	38,068
Total assets	794,436,573
Liabilities
Payable upon return of securities loaned	15,736,500
Payable for Fund shares redeemed	195,229
Accrued management fee	386,177
Accrued Trustees' fees	6,849
Other accrued expenses and payables	580,610
Total liabilities	16,905,365
Net assets, at value	$777,531,208
Net Assets Consist of
Distributable earnings (loss)	91,950,533
Paid-in capital	685,580,675
Net assets, at value	$777,531,208

Represents collateral on securities loaned. In addition, the Fund held non-cash collateral having a value of $5,595,865.

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

Statement of Assets and Liabilities as of November 30, 2025 (continued)

Net Asset Value
Class A
Net Asset Valueand redemption price per share ($679,238,904 ÷ 12,460,576 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized)	$54.51
Maximum offering price per share (100 ÷ 94.25 of $54.51)	$57.84
Class C
Net Asset Value,offering and redemption price (subject to contingent deferred sales charge) per share ($7,100,251 ÷ 130,720 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized)	$54.32
Class S
Net Asset Value,offering and redemption price per share ($25,907,700 ÷ 475,160 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized)	$54.52
Institutional Class
Net Asset Value,offering and redemption price per share ($65,284,353 ÷ 1,196,714 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized)	$54.55

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

Statement of Operations

for the year ended November 30, 2025

Investment Income
Income:
Dividends	$30,782,368
Income distributions -DWS Central Cash Management Government Fund	190,413
Affiliated securities lending income	4,493
Total income	30,977,274
Expenses:
Management fee	5,010,350
Services to shareholders	1,137,451
Distribution and service fees	1,736,196
Custodian fee	9,837
Professional fees	82,729
Reports to shareholders	51,952
Registration fees	76,017
Trustees' fees and expenses	25,873
Other	351,244
Total expenses before expense reductions	8,481,649
Expense reductions	(6,848 )
Total expenses after expense reductions	8,474,801
Net investment income	22,502,473
Realized and Unrealized Gain (Loss)
Net realized gain (loss) from investments	87,488,662
Change in net unrealized appreciation (depreciation) on investments	(150,114,078 )
Net gain (loss)	(62,625,416 )
Net increase (decrease) in net assets resulting from operations	$(40,122,943 )

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

Statements of Changes in Net Assets

	Years Ended November 30,
Increase (Decrease) in Net Assets	2025	2024
Operations:
Net investment income	$22,502,473	$20,962,718
Net realized gain (loss)	87,488,662	59,903,930
Change in net unrealized appreciation (depreciation)	(150,114,078 )	130,500,227
Net increase (decrease) in net assets resulting from operations	(40,122,943 )	211,366,875
Distributions to shareholders:
Class A	(62,768,977 )	(42,398,413 )
Class C	(637,062 )	(462,345 )
Class R	-	(10,156 )*
Class R6	-	(23,831 )*
Class S	(2,915,288 )	(2,218,352 )
Institutional Class	(7,382,366 )	(5,221,718 )
Total distributions	(73,703,693 )	(50,334,815 )
Fund share transactions:
Proceeds from shares sold	26,425,922	35,033,227
Reinvestment of distributions	70,104,655	47,869,401
Payments for shares redeemed	(149,603,201 )	(143,879,097 )
Net increase (decrease) in net assets from Fund share transactions	(53,072,624 )	(60,976,469 )
Increase (decrease) in net assets	(166,899,260 )	100,055,591
Net assets at beginning of period	944,430,468	844,374,877
Net assets at end of period	$777,531,208	$944,430,468

*	For the period from December 1, 2023 to March 25, 2024 (Class R and Class R6 liquidation date).

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

Financial Highlights

DWS CROCI®Equity Dividend Fund -Class A
	Years Ended November 30,
	2025	2024	2023	2022	2021
Selected Per Share Data
Net asset value, beginning of period	$61.78	$51.61	$56.47	$54.61	$49.82
Income (loss) from investment operations:
Net investment incomea	1.46	1.30	1.35	1.39	1.12
Net realized and unrealized gain (loss)	(3.90 )	11.98	(2.84 )	5.69	5.07
Total from investment operations	(2.44 )	13.28	(1.49 )	7.08	6.19
Less distributions from:
Net investment income	(1.33 )	(1.44 )	(1.43 )	(1.30 )	(1.40 )
Net realized gains	(3.50 )	(1.67 )	(1.94 )	(3.92 )	-
Total distributions	(4.83 )	(3.11 )	(3.37 )	(5.22 )	(1.40 )
Net asset value, end of period	$54.51	$61.78	$51.61	$56.47	$54.61
Total Return (%)b	(3.84 )	26.84	(2.59 )	13.66	12.49
Ratios to Average Net Assets and Supplemental Data
Net assets, end of period ($ millions)	679	805	712	804	774
Ratio of expenses (%)	1.06	1.02	1.02	1.02	1.01
Ratio of net investment income (%)	2.71	2.33	2.60	2.58	2.02
Portfolio turnover rate (%)	100	42	60	55	46

a	Based on average shares outstanding during the period.
b	Total return does not reflect the effect of any sales charges.

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

DWS CROCI®Equity Dividend Fund -Class C
	Years Ended November 30,
	2025	2024	2023	2022	2021
Selected Per Share Data
Net asset value, beginning of period	$61.56	$51.45	$56.26	$54.41	$49.65
Income (loss) from investment operations:
Net investment incomea	1.05	.85	.95	.94	.66
Net realized and unrealized gain (loss)	(3.88 )	11.94	(2.81 )	5.69	5.07
Total from investment operations	(2.83 )	12.79	(1.86 )	6.63	5.73
Less distributions from:
Net investment income	(.91 )	(1.01 )	(1.01 )	(.86 )	(.97 )
Net realized gains	(3.50 )	(1.67 )	(1.94 )	(3.92 )	-
Total distributions	(4.41 )	(2.68 )	(2.95 )	(4.78 )	(.97 )
Net asset value, end of period	$54.32	$61.56	$51.45	$56.26	$54.41
Total Return (%)b	(4.56 )c	25.82 c	(3.30 )c	12.74 c	11.57
Ratios to Average Net Assets and Supplemental Data
Net assets, end of period ($ millions)	7	9	10	14	14
Ratio of expenses before expense reductions (%)	1.90	1.85	1.83	1.83	1.83
Ratio of expenses after expense reductions (%)	1.82	1.82	1.77	1.83	1.83
Ratio of net investment income (%)	1.95	1.54	1.83	1.76	1.21
Portfolio turnover rate (%)	100	42	60	55	46

a	Based on average shares outstanding during the period.
b	Total return does not reflect the effect of any sales charges.
c	Total return would have been lower had certain expenses not been reduced.

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

DWS CROCI®Equity Dividend Fund -Class S
	Years Ended November 30,
	2025	2024	2023	2022	2021
Selected Per Share Data
Net asset value, beginning of period	$61.78	$51.61	$56.46	$54.59	$49.80
Income (loss) from investment operations:
Net investment incomea	1.59	1.43	1.47	1.50	1.20
Net realized and unrealized gain (loss)	(3.90 )	11.98	(2.83 )	5.69	5.09
Total from investment operations	(2.31 )	13.41	(1.36 )	7.19	6.29
Less distributions from:
Net investment income	(1.45 )	(1.57 )	(1.55 )	(1.40 )	(1.50 )
Net realized gains	(3.50 )	(1.67 )	(1.94 )	(3.92 )	-
Total distributions	(4.95 )	(3.24 )	(3.49 )	(5.32 )	(1.50 )
Net asset value, end of period	$54.52	$61.78	$51.61	$56.46	$54.59
Total Return (%)	(3.61 )	27.13	(2.35 )	13.90	12.70
Ratios to Average Net Assets and Supplemental Data
Net assets, end of period ($ millions)	26	37	37	45	41
Ratio of expenses (%)	.82	.78	.79	.80	.82
Ratio of net investment income (%)	2.95	2.58	2.82	2.79	2.20
Portfolio turnover rate (%)	100	42	60	55	46

a	Based on average shares outstanding during the period.

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

DWS CROCI®Equity Dividend Fund -Institutional Class
	Years Ended November 30,
	2025	2024	2023	2022	2021
Selected Per Share Data
Net asset value, beginning of period	$61.82	$51.65	$56.52	$54.63	$49.85
Income (loss) from investment operations:
Net investment incomea	1.60	1.44	1.49	1.55	1.26
Net realized and unrealized gain (loss)	(3.90 )	11.99	(2.84 )	5.70	5.07
Total from investment operations	(2.30 )	13.43	(1.35 )	7.25	6.33
Less distributions from:
Net investment income	(1.47 )	(1.59 )	(1.58 )	(1.44 )	(1.55 )
Net realized gains	(3.50 )	(1.67 )	(1.94 )	(3.92 )	-
Total distributions	(4.97 )	(3.26 )	(3.52 )	(5.36 )	(1.55 )
Net asset value, end of period	$54.55	$61.82	$51.65	$56.52	$54.63
Total Return (%)	(3.60 )	27.15	(2.32 )	14.01	12.76 b
Ratios to Average Net Assets and Supplemental Data
Net assets, end of period ($ millions)	65	93	85	105	107
Ratio of expenses before expense reductions (%)	.80	.76	.76	.72	.78
Ratio of expenses after expense reductions (%)	.80	.76	.76	.72	.76
Ratio of net investment income (%)	2.97	2.59	2.85	2.88	2.28
Portfolio turnover rate (%)	100	42	60	55	46

a	Based on average shares outstanding during the period.
b	Total return would have been lower had certain expenses not been reduced.

The accompanying notes are an integral part of the financial statements.

DWS CROCI®Equity Dividend Fund

Notes to Financial Statements

Organization and Significant Accounting Policies

DWS CROCI®Equity Dividend Fund (the "Fund" ) is a diversified series of Deutsche DWS Investment Trust (the "Trust" ), which is registered under the Investment Company Act of 1940, as amended (the "1940 Act" ), as an open-end management investment company organized as a Massachusetts business trust.

The Fund offers multiple classes of shares which provide investors with different purchase options. Class A shares are subject to an initial sales charge. Class C shares are not subject to an initial sales charge but are subject to higher ongoing expenses than Class A shares and a contingent deferred sales charge payable upon certain redemptions within one year of purchase. Class C shares automatically convert to Class A shares in the same fund after 8 years, provided that the Fund or the financial intermediary through which the shareholder purchased the Class C shares has records verifying that the Class C shares have been held for at least 8 years. Class S shares are not subject to initial or contingent deferred sales charges and are available through certain intermediary relationships with financial services firms, or can be purchased by establishing an account directly with the Fund's transfer agent. Institutional Class shares are not subject to initial or contingent deferred sales charges and are generally available only to qualified institutions.

Investment income, realized and unrealized gains and losses, and certain fund-level expenses and expense reductions, if any, are borne pro rata on the basis of relative net assets by the holders of all classes of shares, except that each class bears certain expenses unique to that class such as distribution and service fees, services to shareholders and certain other class-specific expenses. Differences in class-level expenses may result in payment of different per share dividends by class. All shares of the Fund have equal rights with respect to voting subject to class-specific arrangements.

The Fund's financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP" ) which require the use of management estimates. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The Fund qualifies as an investment company under Topic 946 of Accounting Standards Codification of U.S. GAAP. The policies described below are followed consistently by the Fund in the preparation of its financial statements.

Operating Segment. In this reporting period, the Fund adopted FASB Accounting Standards Update 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures ("ASU 2023-07" ).

DWS CROCI®Equity Dividend Fund

Adoption of the new standard impacted financial statement disclosures only and did not affect the Fund's financial position or the results of its operations. An operating segment is defined in Topic 280 as a component of a public entity that engages in business activities from which it may recognize revenues and incur expenses, has operating results that are regularly reviewed by the public entity's chief operating decision maker (CODM) to make decisions about resources to be allocated to the segment and assess its performance, and has discrete financial information available. The President and Chief Executive Officer acts as the Fund's CODM. The Fund represents a single operating segment, as the CODM monitors the operating results of the Fund as a whole, and the Fund's long-term strategic asset allocation is pre-determined in accordance with the terms of its prospectus, based on a defined investment strategy that is executed by the Fund's portfolio managers as a team. The financial information in the form of the Fund's portfolio composition, total returns, expense ratios and changes in net asset (i.e., changes in net assets resulting from operations, subscriptions and redemptions), which are used by the CODM to assess the segment's performance versus the Fund's comparative benchmarks and to make resource allocation decisions for the Fund's single segment, is consistent with that presented within the Fund's financial statements. Segment assets are reflected on the accompanying Statement of Assets and Liabilities as "total assets" and results of operations and significant segment expenses are listed on the accompanying Statement of Operations.

Security Valuation. Investments are stated at value determined as of the close of regular trading on the New York Stock Exchange on each day the exchange is open for trading.

The Fund's Board has designated DWS Investment Management Americas, Inc. (the "Advisor" ) as the valuation designee for the Fund pursuant to Rule 2a-5 under the 1940 Act. The Advisor's Pricing Committee (the "Pricing Committee" ) typically values securities using readily available market quotations or prices supplied by independent pricing services (which are considered fair values under Rule 2a-5). The Advisor has adopted fair valuation procedures that provide methodologies for fair valuing securities.

DWS CROCI®Equity Dividend Fund

Equity securities are valued at the most recent sale price or official closing price reported on the exchange (U.S. or foreign) or over-the-counter market on which they trade. Securities for which no sales are reported are valued at the calculated mean between the most recent bid and asked quotations on the relevant market or, if a mean cannot be determined, at the most recent bid quotation. Equity securities are generally categorized as Level 1. For certain international equity securities, in order to adjust for events which may occur between the close of the foreign exchanges and the close of the New York Stock Exchange, a fair valuation model may be used. This fair valuation model takes into account comparisons to the valuation of American Depository Receipts (ADRs), exchange-traded funds, futures contracts and certain indices and these securities are categorized as Level 2.

Investments in open-end investment companies are valued at their net asset value each business day and are categorized as Level 1.

Securities and other assets for which market quotations are not readily available or for which the above valuation procedures are deemed not to reflect fair value are valued in a manner that is intended to reflect their fair value as determined in accordance with procedures approved by the Pricing Committee and are generally categorized as Level 3. In accordance with the Fund's valuation procedures, factors considered in determining value may include, but are not limited to, the type of the security; the size of the holding; the initial cost of the security; the existence of any contractual restrictions on the security's disposition; the price and extent of public trading in similar securities of the issuer or of comparable companies; quotations or evaluated prices from broker-dealers and/or pricing services; information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities); an analysis of the company's or issuer's financial statements; an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold; and with respect to debt securities, the maturity, coupon, creditworthiness, currency denomination and the movement of the market in which the security is normally traded. The value determined under these procedures may differ from published values for the same securities.

Disclosure about the classification of fair value measurements is included in a table following the Fund's Investment Portfolio.

Foreign Currency Translations. The books and records of the Fund are maintained in U.S. dollars. Investment securities and other assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the prevailing exchange rates at period end. Purchases and sales of investment securities, income and expenses are translated into U.S. dollars at the prevailing exchange rates on the respective dates of the transactions.

DWS CROCI®Equity Dividend Fund

Net realized and unrealized gains and losses on foreign currency transactions represent net gains and losses between trade and settlement dates on securities transactions, the acquisition and disposition of foreign currencies, and the difference between the amount of net investment income accrued and the U.S. dollar amount actually received. The portion of both realized and unrealized gains and losses on investments that results from fluctuations in foreign currency exchange rates is not separately disclosed but is included with net realized and unrealized gain/appreciation and loss/depreciation on investments.

Securities Lending. National Financial Services LLC (Fidelity Agency Lending), as securities lending agent, lends securities of the Fund to certain financial institutions under the terms of its securities lending agreement. During the term of the loans, the Fund continues to receive interest and dividends generated by the securities and to participate in any changes in their market value. The Fund requires the borrowers of the securities to maintain collateral with the Fund consisting of cash and/or securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities having a value at least equal to the value of the securities loaned. When the collateral falls below specified amounts, the securities lending agent will use its best efforts to obtain additional collateral on the next business day to meet required amounts under the securities lending agreement. During the year ended November 30, 2025, the Fund invested the cash collateral, if any, into a joint trading account in affiliated money market funds, including DWS Government & Agency Securities Portfolio, managed by DWS Investment Management Americas, Inc. DWS Investment Management Americas, Inc. receives a management/ administration fee (0.14% annualized effective rate as of November 30, 2025) on the cash collateral invested in DWS Government & Agency Securities Portfolio. The Fund receives compensation for lending its securities either in the form of fees or by earning interest on invested cash collateral net of borrower rebates and fees paid to a securities lending agent. Either the Fund or the borrower may terminate the loan at any time, and the borrower, after notice, is required to return borrowed securities within a standard time period. There may be risks of delay and costs in recovery of securities or even loss of rights in the collateral should the borrower of the securities fail financially. If the Fund is not able to recover securities lent, the Fund may sell the collateral and purchase a replacement investment in the market, incurring the risk that the value of the replacement security is greater than the value of the collateral. The Fund is also subject to all investment risks associated with the reinvestment of any cash collateral received, including, but not limited to, interest rate, credit and liquidity risk associated with such investments.

As of November 30, 2025, the Fund had securities on loan. The value of the related collateral exceeded the value of the securities loaned at period end.

DWS CROCI®Equity Dividend Fund

Remaining Contractual Maturity of the Agreements as of November 30, 2025

	Overnight and Continuous	˂30 days	Between 30 & 90 days	˃90 days	Total
Securities Lending Transactions
Common Stocks	$21,332,365	$-	$-	$-	$21,332,365
Gross amount of recognized liabilities and cash collateral for securities lending transactions:					$15,736,500
Gross amount of unrecognized liabilities related to non-cash collateral for securities lending transactions:					$5,595,865

Tax Information. The Fund's policy is to comply with the requirements of the Internal Revenue Code of 1986, as amended, which are applicable to regulated investment companies, and to distribute all of its taxable income to its shareholders.

The Fund files tax returns with the Internal Revenue Service, the State of New York, and various other states. Each of the tax years in the four-year period ended November 30, 2025, remains subject to examination by taxing authorities.

Distribution of Income and Gains. Distributions from net investment income of the Fund, if any, are declared and distributed to shareholders quarterly. Net realized gains from investment transactions, in excess of available capital loss carryforwards, would be taxable to the Fund if not distributed, and, therefore, will be distributed to shareholders at least annually. The Fund may also make additional distributions for tax purposes if necessary.

The timing and characterization of certain income and capital gain distributions are determined annually in accordance with federal tax regulations which may differ from accounting principles generally accepted in the United States of America. These differences primarily relate to certain securities sold at a loss. The Fund may utilize a portion of the proceeds from capital shares redeemed as a distribution from net investment income and realized capital gains. As a result, net investment income (loss) and net realized gain (loss) on investment transactions for a reporting period may differ significantly from distributions during such period. Accordingly, the Fund may periodically make reclassifications among certain of its capital accounts without impacting the net asset value of the Fund.

DWS CROCI®Equity Dividend Fund

At November 30, 2025, the Fund's components of distributable earnings (accumulated losses) on a net tax basis were as follows:

Undistributed ordinary income*	$29,476,166
Undistributed long-term capital gains	$67,805,123
Net unrealized appreciation (depreciation) on investments	$(5,330,743 )

At November 30, 2025, the aggregate cost of investments for federal income tax purposes was $797,712,529. The net unrealized depreciation for all investments based on tax cost was $5,330,743. This consisted of aggregate gross unrealized appreciation for all investments for which there was an excess of value over tax cost of $57,899,867 and aggregate gross unrealized depreciation for all investments for which there was an excess of tax cost over value of $63,230,610.

In addition, the tax character of distributions paid to shareholders by the Fund is summarized as follows:

	Years Ended November 30,
	2025	2024
Distributions from ordinary income*	$39,815,856	$37,386,820
Distributions from long-term capital gains	$33,887,837	$12,947,995

*	For tax purposes, short-term capital gain distributions are considered ordinary income distributions.

Expenses. Expenses of the Trust arising in connection with a specific fund are allocated to that fund. Other Trust expenses which cannot be directly attributed to a fund are apportioned among the funds in the Trust based upon the relative net assets or other appropriate measures.

Contingencies. In the normal course of business, the Fund may enter into contracts with service providers that contain general indemnification clauses. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet been made. However, based on experience, the Fund expects the risk of loss to be remote.

Other. Investment transactions are accounted for on a trade date plus one basis for daily net asset value calculations. However, for financial reporting purposes, investment transactions are reported on trade date. Interest income is recorded on the accrual basis. Dividend income is recorded on the ex-dividend date net of foreign withholding taxes. Realized gains and losses from investment transactions are recorded on an identified cost basis. Proceeds from litigation payments, if any, are included in net realized gain (loss) from investments.

DWS CROCI®Equity Dividend Fund

Purchases and Sales of Securities

During the year ended November 30, 2025, purchases and sales of investment securities (excluding short-term investments) aggregated $824,640,980 and $930,317,511, respectively.

Related Parties

Management Agreement. Under the Investment Management Agreement with DWS Investment Management Americas, Inc. ("DIMA" or the "Advisor" ), an indirect, wholly owned subsidiary of DWS Group GmbH & Co. KGaA ("DWS Group" ), the Advisor directs the investments of the Fund in accordance with its investment objectives, policies and restrictions. The Advisor determines the securities, instruments and other contracts relating to investments to be purchased, sold or entered into by the Fund. In addition to portfolio management services, the Advisor provides certain administrative services in accordance with the Investment Management Agreement.

Under the Investment Management Agreement with the Advisor, the Fund pays a monthly management fee based on the average daily net assets of the Fund, computed and accrued daily and payable monthly, at the following annual rates:

First $250 million of the Fund's average daily net assets	.63%
Next $750 million of such net assets	.60%
Next $1.5 billion of such net assets	.58%
Next $2.5 billion of such net assets	.56%
Next $2.5 billion of such net assets	.53%
Next $2.5 billion of such net assets	.52%
Next $2.5 billion of such net assets	.51%
Over $12.5 billion of such net assets	.50%

Accordingly, for the year ended November 30, 2025, the fee pursuant to the Investment Management Agreement was equivalent to an annual rate (exclusive of any applicable waivers/reimbursements) of 0.609% of the Fund's average daily net assets.

For the period from December 1, 2024 through September 30, 2025 (through February 28, 2026 for Class C shares), the Advisor had contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary

DWS CROCI®Equity Dividend Fund

expenses, taxes, brokerage, interest expense and acquired fund fees and expenses) of each class as follows:

Class A	1.03%
Class C	1.78%
Class S	.88%
Institutional Class	.78%

Effective October 1, 2025 through September 30, 2026, the Advisor has contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary expenses, taxes, brokerage, interest expense and acquired fund fees and expenses) of certain classes as follows:

Class A		1.06%
Class S		.91%
Institutional Class		.81%

For the year ended November 30, 2025, fees waived and/or expenses reimbursed for Class C are $6,848.

Service Provider Fees. DWS Service Company ("DSC" ), an affiliate of the Advisor, is the transfer agent, dividend-paying agent and shareholder service agent for the Fund. Pursuant to a sub-transfer agency agreement between DSC and SS&C GIDS, Inc. ("SS&C" ), DSC has delegated certain transfer agent, dividend-paying agent and shareholder service agent functions to SS&C. DSC compensates SS&C out of the shareholder servicing fee it receives from the Fund. For the year ended November 30, 2025, the amounts charged to the Fund by DSC were as follows:

Services to Shareholders	Total Aggregated	Unpaid at November 30, 2025
Class A	$278,926	$45,891
Class C	4,214	688
Class S	7,830	1,276
Institutional Class	1,263	204
	$292,233	$48,059

Pursuant to a fund accounting agreement, DIMA is responsible for computing the daily net asset value per share and maintaining the portfolio and general accounting records of the Fund. DIMA has delegated certain fund accounting and record-keeping services to State Street Bank and Trust Company. The costs and expenses of such delegation are paid by

DWS CROCI®Equity Dividend Fund

DIMA. The Fund paid no fee to DIMA for fund accounting and record-keeping services provided under the fund accounting agreement during the period.

In addition, for the year ended November 30, 2025, the amounts charged to the Fund for recordkeeping and other administrative services provided by unaffiliated third parties, included in the Statement of Operations under "Services to shareholders," were as follows:

Sub-Recordkeeping	Total Aggregated
Class A	$608,327
Class C	13,614
Class S	30,541
Institutional Class	79,992
	$732,474

Distribution and Service Fees. Under the Fund's Class C 12b-1 Plan, DWS Distributors, Inc. ("DDI" ), an affiliate of the Advisor, receives a fee ("Distribution Fee" ) of 0.75% of the average daily net assets of Class C shares. In accordance with the Fund's Underwriting and Distribution Services Agreement, DDI enters into related selling group agreements with various firms at various rates for sales of Class C shares. For the year ended November 30, 2025, the Distribution Fee was as follows:

Distribution Fee	Total Aggregated	Unpaid at November 30, 2025
Class C	$58,989	$4,373

In addition, DDI provides information and administrative services for a fee ("Service Fee" ) to Class A and C shareholders at an annual rate of up to 0.25% of the average daily net assets for each such class. DDI in turn has various agreements with financial services firms that provide these services and pays these fees based upon the assets of shareholder accounts the firms service. For the year ended November 30, 2025, the Service Fee was as follows:

Service Fee	Total Aggregated	Unpaid at November 30, 2025	Annual Rate
Class A	$1,658,962	$267,669	.23%
Class C	18,245	4,538	.23%
	$1,677,207	$272,207

Underwriting Agreement and Contingent Deferred Sales Charge. DDI is the principal underwriter for the Fund. Underwriting commissions paid in connection with the distribution of Class A shares for the year ended November 30, 2025 aggregated $8,851.

DWS CROCI®Equity Dividend Fund

In addition, DDI receives any contingent deferred sales charge ("CDSC" ) from Class C share redemptions occurring within one year of purchase. There is no such charge upon redemption of any share appreciation or reinvested dividends. The CDSC is 1% of the value of the shares redeemed for Class C. For the year ended November 30, 2025, the CDSC for Class C shares aggregated $56. A deferred sales charge of up to 1% is assessed on certain redemptions of Class A shares. For the year ended November 30, 2025, DDI received $153 for Class A shares.

Other Service Fees. Under an agreement with the Fund, DIMA is compensated for providing regulatory filing services to the Fund. For the year ended November 30, 2025, the amount charged to the Fund by DIMA included in the Statement of Operations under "Reports to shareholders" aggregated $1,020, of which $302 is unpaid.

Trustees' Fees and Expenses. The Fund paid retainer fees to each Trustee not affiliated with the Advisor, plus specified amounts to the Board Chairperson and to each committee Chairperson.

Affiliated Cash Management Vehicles. The Fund may invest uninvested cash balances in DWS Central Cash Management Government Fund, an affiliated money market fund which is managed by the Advisor. DWS Central Cash Management Government Fund is managed in accordance with Rule 2a-7 under the 1940 Act, which governs the quality, maturity, diversity and liquidity of instruments in which a money market fund may invest and seeks to maintain a stable net asset value. The Fund indirectly bears its proportionate share of the expenses of its investment in DWS Central Cash Management Government Fund. DWS Central Cash Management Government Fund does not pay the Advisor an investment management fee.

Line of Credit

The Fund and other affiliated funds (the "Participants" ) share in a $345 million revolving credit facility provided by a syndication of banks. The Fund may borrow for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. The Participants are charged an annual commitment fee, which is allocated based on net assets, among each of the Participants. Interest is calculated at a daily fluctuating rate per annum equal to the sum of 0.10% plus the higher of the Federal Funds Effective Rate and the Overnight Bank Funding Rate, plus 1.25%. The Fund may borrow up to a maximum of 33 percent of its net assets under the agreement. The Fund had no outstanding loans at November 30, 2025.

DWS CROCI®Equity Dividend Fund

Fund Share Transactions

The following table summarizes share and dollar activity in the Fund:

	Year Ended November 30, 2025		Year Ended November 30, 2024
	Shares	Dollars	Shares	Dollars
Shares sold
Class A	208,826	$11,331,835	184,329	$10,180,393
Class C	14,339	777,955	5,463	312,357
Class R	-	-	1,083 *	57,228 *
Class R6	-	-	66 *	3,562 *
Class S	52,845	2,772,289	69,842	3,857,091
Institutional Class	215,284	11,543,843	368,071	20,622,596
		$26,425,922		$35,033,227
Shares issued to shareholders in reinvestment of distributions
Class A	1,084,919	$59,344,643	755,566	$40,055,239
Class C	11,639	636,436	8,789	461,394
Class R	-	-	196 *	10,156 *
Class R6	-	-	454 *	23,612 *
Class S	52,827	2,888,559	41,607	2,203,707
Institutional Class	132,193	7,235,017	96,407	5,115,293
		$70,104,655		$47,869,401
Shares redeemed
Class A	(1,861,465 )	$(100,067,485 )	(1,713,318 )	$(94,740,633 )
Class C	(40,413 )	(2,173,539 )	(53,904 )	(2,938,769 )
Class R	-	-	(5,794 )*	(319,917 )*
Class R6	-	-	(10,333 )*	(573,376 )*
Class S	(235,950 )	(12,743,588 )	(217,980 )	(11,960,606 )
Institutional Class	(658,219 )	(34,618,589 )	(603,872 )	(33,345,796 )
		$(149,603,201 )		$(143,879,097 )

DWS CROCI®Equity Dividend Fund

	Year Ended November 30, 2025		Year Ended November 30, 2024
	Shares	Dollars	Shares	Dollars
Net increase (decrease)
Class A	(567,720 )	$(29,391,007 )	(773,423 )	$(44,505,001 )
Class C	(14,435 )	(759,148 )	(39,652 )	(2,165,018 )
Class R	-	-	(4,515 )*	(252,533 )*
Class R6	-	-	(9,813 )*	(546,202 )*
Class S	(130,278 )	(7,082,740 )	(106,531 )	(5,899,808 )
Institutional Class	(310,742 )	(15,839,729 )	(139,394 )	(7,607,907 )
		$(53,072,624 )		$(60,976,469 )

*	For the period from December 1, 2023 to March 25, 2024 (Class R and Class R6 liquidation date).

DWS CROCI®Equity Dividend Fund

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Deutsche DWS Investment Trust and Shareholders of DWS CROCI Equity Dividend Fund:

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities of DWS CROCI Equity Dividend Fund (the "Fund" ) (one of the funds constituting Deutsche DWS Investment Trust (the "Trust" )), including the investment portfolio, as of November 30, 2025, and the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended and the related notes (collectively referred to as the "financial statements" ). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund (one of the funds constituting Deutsche DWS Investment Trust) at November 30, 2025, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended and its financial highlights for each of the five years in the period then ended, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Trust's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB" ) and are required to be independent with respect to the Trust in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Trust is not required to have, nor were we engaged to perform, an audit of the Trust's internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Trust's internal control over financial reporting. Accordingly, we express no such opinion.

DWS CROCI®Equity Dividend Fund

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of November 30, 2025, by correspondence with the custodian, brokers, and others; when replies were not received from brokers and others, we performed other auditing procedures. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

We have served as the auditor of one or more investment companies in the DWS family of funds since at least 1979, but we are unable to determine the specific year.

Boston, Massachusetts

January 22, 2026

DWS CROCI®Equity Dividend Fund

Tax Information (Unaudited)

The Fund paid distributions of $2.23 per share from net long-term capital gains during its year ended November 30, 2025.

Pursuant to Section 852 of the Internal Revenue Code, the Fund designates $86,802,000 as capital gain dividends for its year ended November 30, 2025.

For corporate shareholders, 66% of the ordinary dividends (i.e., income dividends plus short-term capital gains) paid during the Fund's fiscal year ended November 30, 2025, qualified for the dividends received deduction.

For federal income tax purposes, the Fund designates approximately $33,861,000, or the maximum amount allowable under tax law, as qualified dividend income.

Please consult a tax advisor if you have questions about federal or state income tax laws, or on how to prepare your tax returns. If you have specific questions about your account, please call (800) 728-3337.

DWS CROCI®Equity Dividend Fund

Advisory Agreement Board Considerations and Fee Evaluation

The Board of Trustees (hereinafter referred to as the "Board" or "Trustees" ) approved the renewal of DWS CROCI®Equity Dividend Fund's (the "Fund" ) investment management agreement (the "Agreement" ) with DWS Investment Management Americas, Inc. ("DIMA" ) in September 2025.

In terms of the process that the Board followed prior to approving the Agreement, shareholders should know that:

During the entire process, all of the Fund's Trustees were independent of DIMA and its affiliates (the "Independent Trustees" ).

The Board met frequently during the past year to discuss fund matters and dedicated a substantial amount of time to contract review matters. Over the course of several months, the Board reviewed extensive materials received from DIMA, independent third parties and independent counsel, including materials containing information on the Fund's performance, fees and expenses, profitability, economies of scale and fall-out benefits.

The Board also received extensive information throughout the year regarding performance of the Fund.

The Independent Trustees regularly met privately with counsel to discuss contract review and other matters.

In connection with reviewing the Agreement, the Board also reviewed the terms of the Fund's Rule 12b-1 plan, distribution agreement, transfer agency agreement, and certain other material service agreements.

In connection with the contract review process, the Board considered the factors discussed below, among others. The Board also considered that DIMA and its predecessors have managed the Fund since its inception, and the Board believes that a long-term relationship with a capable, conscientious advisor is in the best interests of the Fund. The Board considered, generally, that shareholders chose to invest or remain invested in the Fund knowing that DIMA managed the Fund. DIMA is part of DWS Group GmbH & Co. KGaA ("DWS Group" ). DWS Group is a global asset management business that offers a wide range of investing expertise and resources, including research capabilities in many countries throughout the world. DWS Group is majority-owned by Deutsche Bank AG, with approximately 20% of its shares publicly traded.

As part of the contract review process, the Board carefully considered the fees and expenses of each DWS fund overseen by the Board in light of the fund's performance. In many cases, this led to the negotiation and implementation of expense caps.

DWS CROCI®Equity Dividend Fund

While shareholders may focus primarily on fund performance and fees, the Board considers these and many other factors, including the quality and integrity of DIMA's personnel and administrative support services provided by DIMA, such as back-office operations, fund valuations, and compliance policies and procedures.

Nature, Quality and Extent of Services. The Board considered the terms of the Agreement, including the scope of advisory services provided under the Agreement. The Board noted that, under the Agreement, DIMA provides portfolio management services and administrative services to the Fund. The Board considered the experience and skills of senior management and investment personnel and the resources made available to such personnel. The Board also considered the risks to DIMA in sponsoring or managing the Fund, including financial, operational and reputational risks, the potential economic impact to DIMA from such risks and DIMA's approach to addressing such risks. The Board reviewed the Fund's performance over short-term and long-term periods and compared those returns to various agreed-upon performance measures, including market index(es) and a peer universe compiled using information supplied by Morningstar Direct ("Morningstar" ), an independent fund data service. The Board also noted that it has put into place a process of identifying "Funds in Review" (e.g., funds performing poorly relative to a peer universe), and receives additional reporting from DIMA regarding such funds and, where appropriate, DIMA's plans to address underperformance. The Board believes this process is an effective manner of identifying and addressing underperforming funds. Based on the information provided, the Board noted that, for the one-, three- and five-year periods ended December 31, 2024, the Fund's performance (Class A shares) was in the 3rd quartile, 2nd quartile and 4th quartile, respectively, of the applicable Morningstar universe (the 1st quartile being the best performers and the 4th quartile being the worst performers). The Board also observed that the Fund has outperformed its benchmark in the three-year period and has underperformed its benchmark in the one- and five-year periods ended December 31, 2024.

Fees and Expenses. The Board considered the Fund's investment management fee schedule, operating expenses and total expense ratios, and comparative information provided by Broadridge Financial Solutions, Inc. ("Broadridge" ) regarding investment management fee rates paid to other investment advisors by similar funds (1st quartile being the most favorable and 4th quartile being the least favorable). With respect to management fees paid to other investment advisors by similar funds, the Board noted that the contractual fee rates paid by the Fund were lower than the median (2nd quartile) of the applicable Broadridge peer group (based on Broadridge data provided as of December 31, 2024). The Board noted that the Fund's Class A shares total (net) operating expenses (excluding 12b-1 fees) were expected to be higher than the median (3rd

DWS CROCI®Equity Dividend Fund

quartile) of the applicable Broadridge expense universe (based on Broadridge data provided as of December 31, 2024, and analyzing Broadridge expense universe Class A (net) expenses less any applicable 12b-1 fees) ("Broadridge Universe Expenses" ). The Board also reviewed data comparing each other operational share class's total (net) operating expenses to the applicable Broadridge Universe Expenses. The Board noted that the expense limitations agreed to by DIMA were expected to help the Fund's total (net) operating expenses remain competitive. The Board considered the Fund's management fee rate as compared to fees charged by DIMA to comparable DWS U.S. registered funds ("DWS Funds" ) and considered differences between the Fund and the comparable DWS Funds. The information requested by the Board as part of its review of fees and expenses also included information about institutional accounts (including any sub-advised funds and accounts) and funds offered primarily to European investors ("DWS Europe Funds" ) managed by DWS Group. The Board noted that DIMA indicated that DWS Group does not manage any institutional accounts or DWS Europe Funds comparable to the Fund.

On the basis of the information provided, the Board concluded that management fees were reasonable and appropriate in light of the nature, quality and extent of services provided by DIMA.

Profitability. The Board reviewed detailed information regarding revenues received by DIMA under the Agreement. The Board considered the estimated costs to DIMA, and pre-tax profits realized by DIMA, from advising the DWS Funds, as well as estimates of the pre-tax profits attributable to managing the Fund in particular. The Board also received information regarding the estimated enterprise-wide profitability of DIMA and its affiliates with respect to all fund services in totality and by fund. The Board reviewed DIMA's methodology in allocating its costs to the management of the Fund. Based on the information provided, the Board concluded that the pre-tax profits realized by DIMA in connection with the management of the Fund were not unreasonable. The Board also reviewed certain publicly available information regarding the profitability of certain similar investment management firms. The Board noted that, while information regarding the profitability of such firms is limited (and in some cases is not necessarily prepared on a comparable basis), DIMA and its affiliates' overall profitability with respect to the DWS Funds (after taking into account distribution and other services provided to the funds by DIMA and its affiliates) was in line with the overall profitability levels of most comparable firms for which such data was available.

Economies of Scale. The Board considered whether there are economies of scale with respect to the management of the Fund and whether the Fund benefits from any economies of scale. The Board noted that the Fund's investment management fee schedule includes fee breakpoints.

DWS CROCI®Equity Dividend Fund

The Board concluded that the Fund's fee schedule represents an appropriate sharing between the Fund and DIMA of such economies of scale as may exist in the management of the Fund at current asset levels.

Other Benefits to DIMA and Its Affiliates. The Board also considered the character and amount of other incidental or "fall-out" benefits received by DIMA and its affiliates, including any fees received by an affiliate of DIMA for transfer agency services provided to the Fund and any fees received by an affiliate of DIMA for distribution services. The Board noted that DIMA pays a licensing fee to an affiliate related to the Fund's use of the CROCI® strategy. The Board also considered benefits to DIMA related to brokerage and soft-dollar allocations, including allocating brokerage to pay for research generated by parties other than the executing broker dealers, which pertain primarily to funds investing in equity securities. In addition, the Board considered the incidental public relations benefits to DIMA related to DWS Funds advertising and cross-selling opportunities among DIMA products and services. The Board considered these benefits in reaching its conclusion that the Fund's management fees were reasonable.

Compliance. The Board considered the significant attention and resources dedicated by DIMA to its compliance processes. The Board noted in particular (i) the experience, seniority and time commitment of the individuals serving as DIMA's and the Fund's chief compliance officers; (ii) the substantial commitment of resources by DIMA and its affiliates to compliance matters; and (iii) ongoing efforts to enhance the compliance program.

Based on all of the information considered and the conclusions reached, the Board determined that the continuation of the Agreement is in the best interests of the Fund. In making this determination, the Board did not give particular weight to any single factor identified above and individual Independent Trustees may have weighed these factors differently in reaching their individual decisions to approve the continuation of the Agreement. The Board considered these factors over the course of numerous meetings, certain of which were in executive session with only the Independent Trustees and counsel present.

DCEDF-BFE2025

DWS CROCI®Equity Dividend Fund

DCEDF-NCSRA

	(b) The Financial Highlights are included with the Financial Statements under Item 7(a).

Item 8.	Changes in and Disagreements with Accountants for Open-End Management Investment Companies.

	Not applicable

Item 9.	Proxy Disclosures for Open-End Management Investment Companies.

	Not applicable

Item 10.	Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.

	See Item 7(a)

Item 11.	Statement Regarding Basis for Approval of Investment Advisory Contract.

	See Item 7(a)

Item 12.	Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

	Not applicable

Item 13.	Portfolio Managers of Closed-End Management Investment Companies.

	Not applicable

Item 14.	Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

	Not applicable

Item 15.	Submission of Matters to a Vote of Security Holders.

	There were no material changes to the procedures by which shareholders may recommend nominees to the Fund's Board. The primary function of the Nominating and Governance Committee is to identify and recommend individuals for membership on the Board and oversee the administration of the Board Governance Guidelines. Shareholders may recommend candidates for Board positions by forwarding their correspondence by U.S. mail or courier service to Keith R. Fox, DWS Funds Board Chair, c/o Thomas R. Hiller, Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, MA 02199-3600.

Item 16.	Controls and Procedures.

	(a)	The Chief Executive and Financial Officers concluded that the Registrant's Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.

	(b)	There have been no changes in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal controls over financial reporting.

Item 17.	Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

	Not applicable

Item 18.	Recovery of Erroneously Awarded Compensation.

	Not applicable

Item 19.	Exhibits

	(a)(1)	Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH.

	(a)(2)	Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

	(b)	Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Registrant:	DWS CROCI® Equity Dividend Fund, a series of Deutsche DWS Investment Trust


By:	/s/Hepsen Uzcan Hepsen Uzcan Principal Executive Officer

Date:	1/29/2026

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:	/s/Hepsen Uzcan Hepsen Uzcan Principal Executive Officer

Date:	1/29/2026



By:	/s/Diane Kenneally Diane Kenneally Principal Financial Officer

Date:	1/29/2026

Deutsche Investment Trust published this content on February 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 02, 2026 at 14:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format

related announcements

Company News

Financial Services

Deutsche Investment Trust

Annual Report by Investment Company (Form N-CSR)

DWS CROCI® Equity Dividend Fund

Class A: KDHAX

Annual Shareholder Report - November 30, 2025

What were the Fund costs for the last year?

How did the Fund perform last year and what affected its performance?

Fund Performance

Cumulative Growth of an Assumed $10,000 Investment

(Adjusted for Maximum Sales Charge)

Average Annual Total Returns

Key Fund Statistics

What did the Fund invest in?

Asset Allocation

Sector Allocation

Ten Largest Equity Holdings

Material Fund Changes

Additional Information

Householding

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

©2026 DWS Group GmbH&Co. KGaA. All rights reserved

DCEDF-TSRA-A

R-103926-2 (01/26)

DWS CROCI® Equity Dividend Fund

Class C: KDHCX

Annual Shareholder Report - November 30, 2025

What were the Fund costs for the last year?

How did the Fund perform last year and what affected its performance?

Fund Performance

Cumulative Growth of an Assumed $10,000 Investment

Average Annual Total Returns

Key Fund Statistics

What did the Fund invest in?

Asset Allocation

Sector Allocation

Ten Largest Equity Holdings

Additional Information

Householding

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

©2026 DWS Group GmbH&Co. KGaA. All rights reserved

DCEDF-TSRA-C

R-103926-2 (01/26)

DWS CROCI® Equity Dividend Fund

Class S: KDHSX

Annual Shareholder Report - November 30, 2025

What were the Fund costs for the last year?

How did the Fund perform last year and what affected its performance?

Fund Performance

Cumulative Growth of an Assumed $10,000 Investment

Average Annual Total Returns

Key Fund Statistics

What did the Fund invest in?

Asset Allocation

Sector Allocation

Ten Largest Equity Holdings

Material Fund Changes

Additional Information

Householding

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.

©2026 DWS Group GmbH&Co. KGaA. All rights reserved

DCEDF-TSRA-S

R-103926-2 (01/26)

DWS CROCI® Equity Dividend Fund

Institutional Class: KDHIX

Annual Shareholder Report - November 30, 2025

What were the Fund costs for the last year?

How did the Fund perform last year and what affected its performance?

Fund Performance

Cumulative Growth of an Assumed $1,000,000 Investment

Average Annual Total Returns

Key Fund Statistics

What did the Fund invest in?

Asset Allocation

Sector Allocation

Ten Largest Equity Holdings

Material Fund Changes

Additional Information

DWS CROCI^® Equity Dividend Fund

DWS CROCI^® Equity Dividend Fund

DWS CROCI^® Equity Dividend Fund

DWS CROCI^® Equity Dividend Fund